Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Return on Assets: 2018-2025

Historic Return on Assets for Crinetics Pharmaceuticals (CRNX) over the last 7 years, with Sep 2025 value amounting to -0.34%.

  • Crinetics Pharmaceuticals' Return on Assets fell 5.00% to -0.34% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.34%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.29% for FY2024, which is 14.00% up from last year.
  • Crinetics Pharmaceuticals' Return on Assets amounted to -0.34% in Q3 2025, which was down 22.03% from -0.28% recorded in Q2 2025.
  • In the past 5 years, Crinetics Pharmaceuticals' Return on Assets ranged from a high of -0.23% in Q1 2025 and a low of -0.61% during Q2 2023.
  • Its 3-year average for Return on Assets is -0.35%, with a median of -0.29% in 2024.
  • Its Return on Assets has fluctuated over the past 5 years, first fell by 26bps in 2023, then skyrocketed by 34bps in 2024.
  • Over the past 5 years, Crinetics Pharmaceuticals' Return on Assets (Quarterly) stood at -0.35% in 2021, then dropped by 9bps to -0.44% in 2022, then climbed by 12bps to -0.33% in 2023, then increased by 8bps to -0.25% in 2024, then dropped by 5bps to -0.34% in 2025.
  • Its last three reported values are -0.34% in Q3 2025, -0.28% for Q2 2025, and -0.23% during Q1 2025.